.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
US Department of Justice
Colorcon
Boehringer Ingelheim
Federal Trade Commission
Johnson and Johnson
Farmers Insurance
Dow
UBS
Express Scripts

Generated: June 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 203112

« Back to Dashboard
NDA 203112 describes QUININE SULFATE, which is a drug marketed by Lupin Ltd, Amneal Pharms, Teva Pharms, Riconpharma Llc, and Mylan Pharms Inc, and is included in five NDAs. It is available from seven suppliers. Additional details are available on the QUININE SULFATE profile page.

The generic ingredient in QUININE SULFATE is quinine sulfate. There are eleven drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the quinine sulfate profile page.

Summary for NDA: 203112

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Antiparasitics
Formulation / Manufacturing:see details

Pharmacology for NDA: 203112

Suppliers and Packaging for NDA: 203112

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
QUININE SULFATE
quinine sulfate
CAPSULE;ORAL 203112 ANDA Lupin Pharmaceuticals, Inc. 68180-560 68180-560-01 100 CAPSULE in 1 BOTTLE (68180-560-01)
QUININE SULFATE
quinine sulfate
CAPSULE;ORAL 203112 ANDA Lupin Pharmaceuticals, Inc. 68180-560 68180-560-02 500 CAPSULE in 1 BOTTLE (68180-560-02)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength324MG
Approval Date:Apr 24, 2015TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Fuji
Merck
Harvard Business School
QuintilesIMS
Colorcon
McKinsey
Cerilliant
Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot